A Novel Synthetic Acyclic Lipid A-like Agonist Activates Cells via the Lipopolysaccharide/Toll-like Receptor 4 Signaling Pathway
Open Access
- 1 January 2001
- journal article
- Published by Elsevier in Journal of Biological Chemistry
- Vol. 276 (3) , 1873-1880
- https://doi.org/10.1074/jbc.m009040200
Abstract
No abstract availableKeywords
This publication has 51 references indexed in Scilit:
- Cellular Events Mediated by Lipopolysaccharide-stimulated Toll-like Receptor 4Journal of Biological Chemistry, 2000
- The Toll-like Receptor Protein Rp105 Regulates Lipopolysaccharide Signaling in B CellsThe Journal of Experimental Medicine, 2000
- Host Defense Mechanisms Triggered by Microbial Lipoproteins Through Toll-Like ReceptorsScience, 1999
- Endotoxin-tolerant Mice Have Mutations in Toll-like Receptor 4 (Tlr4)The Journal of Experimental Medicine, 1999
- CD14: Cell surface receptor and differentiation markerImmunology Today, 1993
- Lipopolysaccharide antagonistsImmunology Today, 1992
- Structure and Function of Lipopolysaccharide Binding ProteinScience, 1990
- CD14, a Receptor for Complexes of Lipopolysaccharide (LPS) and LPS Binding ProteinScience, 1990
- Lipid IVA inhibits synthesis and release of tumor necrosis factor induced by lipopolysaccharide in human whole blood ex vivo.The Journal of Experimental Medicine, 1990
- BIOCHEMISTRY OF ENDOTOXINSAnnual Review of Biochemistry, 1990